Toxoplasma gondii
is an intracellular protozoan parasite of global importance that can remarkably infect, survive, and replicate in nearly all mammalian cells. Notably, 110 years after its discovery, Toxoplasmosis is still a neglected parasitic infection. Although most human infections with
T. gondii
are mild or asymptomatic,
T. gondii
infection can result in life-threatening disease in immunocompromised individuals and in the developing fetus due to congenital infection, underscoring the role of the host immune system in controlling the parasite. Recent evidence indicates that
T. gondii
elicits a robust innate immune response during infection. Interestingly, however,
T. gondii
has evolved strategies to successfully bypass or manipulate the immune system and establish a life-long infection in infected hosts. In particular,
T. gondii
manipulates host immunity through the control of host gene transcription and dysregulation of signaling pathways that result in modulation of cell adhesion and migration, secretion of immunoregulatory cytokines, production of microbicidal molecules, and apoptosis. Many of these host-pathogen interactions are governed by parasite effector proteins secreted from the apical secretory organelles, including the rhoptries and dense granules. Here, we review recent findings on mechanisms by which
T. gondii
evades host innate immunity, with a focus on parasite evasion of the human innate immune system.